PODD stock rallies 37.4% in a year, fueled by Omnipod 5 adoption, global launches and expanding reach in diabetes care.
Global equities are likely to continue edging higher even as valuation concerns continue to arouse fear among investors.
Biolinq Shine’s use of a microsensor array mitigates the need for an introducer needle for sensor placement as in traditional ...
The San Diego-based company claims a number of firsts for its coin-sized Biolinq Shine device, including that it is so far ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback